Approval · Notice of Compliance 11468 · 2010
NERISONE: Notice of Compliance 11468
Issued June 2, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11468
- Date
- June 2, 2010
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NERISONE | 00587826 | Cancelled Post Market |
| NERISONE | 00587834 | Cancelled Post Market |
| NERISONE (OILY CREAM) | 00587818 | Cancelled Post Market |
Medicinal ingredients
- DIFLUCORTOLONE VALERATE 0.1 PER